Browsing School of Health Sciences by Subject "type 2 diabetes mellitus"
Now showing items 1-1 of 1
-
In Silico Design Of Compounds As Sglt2 Inhibitors
(Central University of Punjab, 2018)SGLT2 inhibitors (SGLT2i) are the current novel therapeutic approach expected to control the growing threat of type 2 diabetes mellitus (T2DM). With comparatively least reported side effects, SGLT2i (gliflozins) have been ...